PMC8077600_01
Evolution of treatment, blood requirement, and biology of the patient during the period of interest. The arrow represents 1 red blood cell pack. The plasmapheresis took place over 10 days, then the patient received 2 cycles of paclitaxel, after which she received eculizumab during 4 weeks. Finally, she was concomitantly treated with palbociclib. C, cure.
cro-0014-0676-g02.jpg
PMC8077600_01_cro-0014-0676-g02.jpg
F2
Figure 2 summarizes all changes in blood requirement, hemoglobin level, platelet count, and specific treatments since November 2018.